This quarterly cash flow report looks awful. However one has to keep in mind that Oventus is not selling a consumer product such as Milk. The O2Vent device requires a prescription by a licensed medical professional. This is a new treatment option for a medical condition that for a long time has been treated using CPAP machines + masks. It is going to take quite a bit of money, sweat, and time to get doctors to prescribe this medical device in lieu of CPAP therapy. The medical profession is understandably very conservative. Oventus hired quality people to lead sales and marketing efforts in the USA. I have never founded nor run a company but I understand that it takes time for a company to grow. It's like planting a seed then waiting for it to grow into a flower or a small tree. Oventus Medical will disrupt the CPAP industry. It's not a matter of if but how fast. The Chairman (Melvin Bridges) knows it and that's why he has been accumulating shares through market purchases.
OVN Price at posting:
32.5¢ Sentiment: Buy Disclosure: Held
